ions with a toxin,"
stated Steven Basta, CEO of BioForm Medical. "We believe that the synergy
of this product with our Radiesse dermal filler will be terrific. We have a
differentiated, long-lasting filler, and in the coming years we hope to
offer physicians a new treatment option for frown lines. This is part of
our commitment to partnering with physicians to offer them improved
aesthetic treatment options that can grow their practices. This device
could appeal to many of the same physicians who select Radiesse dermal
filler for their patients, and will leverage our existing sales and
marketing organization."
In the acquisition of ACI, BioForm Medical will hire several of ACI's
employees, and retain others as consultants to maintain continuity of this
program and to accelerate future product development and commercialization
activities. In addition to the up-front consideration, BioForm Medical will
pay a single-digit royalty to ACI. The Company anticipates that significant
positive revenue impact of this acquisition is not likely until it obtains
clearance for the product for aesthetic applications, anticipated to occur
in calendar year 2009.
BioForm Medical will discuss this transaction further on Thursday, May
1, 2008, when it reports its financial results for the quarter ended March
31, 2008, and holds a conference call with investors at 2:00 p.m. Pacific
Time (5:00 p.m. Eastern Time).
About the ACI Device & the Market for Treatment of Frown Lines:
The ACI device provides a minimally invasive technique for creating a
focal lesion inhibiting the function of the target nerve. The product is
comprised of a RF energy generator box, approximately the size of a small
monitor, a sterile handheld probe and a foot pedal to activate energy
delivery. The probe has two functions -- stimulating the nerve to identify
the proper location for treatment, and delivering the heat energy in a
measured dose to reduce activity of the targeted nerve. The m
'/>"/>
SOURCE BioForm Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 20082.
BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 20083.
BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 20074.
ATS Medical Announces First Frontiers in Cryoablation Symposium5.
Medical journal calls upon Barack Obama to do much more6.
ACP hosts largest medical education meeting for general and subspecialty internists7.
Flashpoint Medica Named Agency of Year by Medical Advertising News8.
Virginia Judge Rules Medical Device Pioneer Committed Malpractice9.
Digirad Corporation and University of Chicago Medical Center Sign Letter of Agreement10.
PSI Corp. Announces Additional Hospitals and Medical Office Buildings to Utilize Its Digital Signage Network11.
Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer